Ten Korean oncologists put their names on the list of the world’s most influential researchers, heightening the status of the country’s medicine.
On Wednesday, Clarivate Plc, a global academic information analysis company, announced the list of Highly Cited Researchers (HCR), a who’s who of researchers with the largest number of ESI Highly Cited Papers, the top 1 percent of most influential researchers worldwide.
The analysts at Clarivate’s Institute for Scientific Information (ISI) analyzed ESI Highly Cited Papers for 11 years from January 2011 to December 2021 and selected 6,938 researchers who have left meaningful effects on their research areas, covering 69 countries or regions and various study areas in both social and natural sciences.
The 2020 HCR list included 70 Korean researchers. Notably, 10 oncology experts put their names on the list in Clinical Medicine and Cross-Field.
Four researchers have put their names on the list for three consecutive years. They are Professor Kim Dong-Wan of Seoul National University Hospital’s Department of Hemato-oncology, Professor Park Geun-chil of Samsung Medical Center’s Department of Hemago-oncology, CEO Bang Yung-je of Bang & Ok Consulting, and Professor Ahn Myung-ju of Samsung Medical Center Department of Hemato-oncology.
Another four researchers put their names on the list for two consecutive years. They are Professor Kang Yoon-koo of Asan Medical Center’s Department of Oncology, Professor Im Seock-ah of Seoul National University Hospital’s Department of Hemato-oncology, Professor Emeritus Chung Hyun-cheol of Yonsei University College of Medicine, and Professor Cho Byoung-chul of Severance Hospital’s Department of Oncology.
Two researchers were listed anew – Professor Lee Ki-hyung of Chungbuk National University Hospital’s Department of Hemato-oncology and Professor Rim Ho-young of Samsung Medical Center’s Department of Hemato-oncology.
Clarivate began to expand its qualitative analysis of the HCR list to dissolve concerns about potential irregularities, including plagiarism, photographic manipulation, and false reviews, this year.
Accordingly, the company ferreted out all irregularities in the papers of candidates by cooperating with Retraction Watch, which reports about scientific papers’ withdrawal and related subjects, and excluded researchers found to have committed scientific irregularities in the course of official procedures involving government agencies, research fund providers, and publishers.